Important Review and Other Articles.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 47
- By:
- Publication type:
- Article
Works matching IS 17927919 AND DT 2021 AND VI 16 AND IP 2
Results: 32
1
2
The O And Rh--Blood Groups May be Associated With a Slightly Lower Risk for SARS-CoV-2 Infection and Severe COVID-19 Illness.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 47
- By:
- Publication type:
- Article
3
Deep Neural Networks Can Predict New-Onset AF from the 12-Lead ECG and Help Identify Those at Risk of AF-Related Stroke.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 46
- By:
- Publication type:
- Article
4
Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval (QTc) Using a Mobile ECG (mECG) Device Can Predict Accurately the QTc of a Standard ECG.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 46
- By:
- Publication type:
- Article
5
Acute Cardiac Injury (ACI) in Severe COVID-19 is a Function of Baseline Comorbidities, Old Age, and Multisystem Organ Dysfunction, Similar to Traditional ARDS / The Adverse Prognosis of ACI in COVID-19 Relates Largely to Multisystem Organ Involvement and Critical Illness.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 46
- By:
- Publication type:
- Article
6
Cardiac Injury in COVID-19/Pathological Study: The Most Common Pathological Cause of Myocyte Necrosis Was Microthrombi.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 46
- By:
- Publication type:
- Article
7
DAPA-HF: Baseline Kidney Function did not Modify the Benefits of Dapagliflozin on Morbidity & Mortality in HFrEF, and Dapagliflozin Slowed the Rate of Decline in eGFR, Including in Patients Without Diabetes.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 46
- By:
- Publication type:
- Article
8
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With the Covid-19 Pandemic: Cardiac Involvement is Common MIS-C Leading to High Levels of NT-proBNP, Ferritin, D-Dimers, and Cardiac Troponin in Addition to High CRP and Procalcitonin Levels / In Comparison With Adults With COVID-19, Mortality in MIS-C is Uncommon Despite Multisystem Involvement, Very Elevated Inflammatory Markers, and Need for ICU Support.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 45
- By:
- Publication type:
- Article
9
Framingham Offspring Cohort: Higher Consumption of Ultra-Processed Foods is Associated With Increased Risk of CVD Incidence and Mortality.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 45
- By:
- Publication type:
- Article
10
EMPEROR-Reduced: Findings Do Not Support a Dominant Role of Diuresis in Mediating the Physiological Changes or Clinical Benefits of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on the Course of Heart Failure (HF) in Patients With a Reduced Ejection Fraction.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 45
- By:
- Publication type:
- Article
11
TOPCAT-Americas: Among HFpEF Patients Spironolactone Increased Risk of Worsening Renal Function (WRF) Compared With Placebo / Rates of CV Death Were Lower With Spironolactone in Both Patients With and Without WRF.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 45
- By:
- Publication type:
- Article
12
Ivabradine is Safe and Effective in Significantly Improving Heart Rate and Quality of Life (QOL) in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS).
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 44
- By:
- Publication type:
- Article
13
Intracranial Atherosclerotic Plaque as a Potential Cause of Embolic Stroke of Undetermined Source.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 44
- By:
- Publication type:
- Article
14
Pooled Analysis of Patient-Level Data Demonstrates that PFO Closure Was Safe and Significantly Reduced the Mean Number of Monthly Migraine Days and Monthly Migraine Attacks, and Resulted in a Greater Number of Subjects Who Experienced Complete Migraine Cessation.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 44
- By:
- Publication type:
- Article
15
SYNTAXES: At 10-Years, the Status of Total Occlusion (TO) Recanalization or Revascularization Did Not Affect Mortality, Irrespective of the Assigned Treatment and Location of TOs / The Present Study Might Support Practice of Recommending Recanalization Primarily for the Management of Angina Refractory to Medical Therapy When Myocardial Viability is Confirmed.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 44
- By:
- Publication type:
- Article
16
MATRIX: Among Patients with Acute Coronary Syndrome (ACS) Managed Invasively, In-Hospital Hemoglobin Drop ≥3 g/dl, Even in the Absence of Overt Bleeding, is Common and is Independently Associated With Increased Risk for 1-Year Mortality.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 44
- By:
- Publication type:
- Article
17
INTCAR (International Cardiac Arrest Registry): Patients Successfully Resuscitated from Cardiac Arrest With 6 or More Unfavorable Features Have a Poor Long-Term Prognosis. Delaying or Even Forgoing Invasive Procedures in Such Patients is Reasonable.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 44
- By:
- Publication type:
- Article
18
EMPA-TROPISM: Empagliflozin in Nondiabetic HFrEF Patients Significantly Improves LV Volumes, LV Mass, LV Systolic Function, Functional Capacity, and Quality of Life When Compared With Placebo.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 43
- By:
- Publication type:
- Article
19
World-Wide Survey: COVID-19 Conferred a Significant and Abrupt Reduction in Cardiovascular Diagnostic Testing Across the Globe, Especially Affecting the Worlds Economically Challenged.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 43
- By:
- Publication type:
- Article
20
The COVID-19 Pandemic May Have Had an Indirect Toll on Patients With Cardiovascular Disease / There was an Increase in Deaths Caused by Ischemic Heart Disease and Hypertensive Diseases in Some Regions of the US During the Initial Phase of the Pandemic.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 43
- By:
- Publication type:
- Article
21
Concomitant Pathology of Aortic Stenosis-Cardiac Amyloidosis (AS-CA) is Common in Older Patients With Aortic Stenosis (AS) and can be Predicted Clinically / AS-CA Has Worse Clinical Presentation and a Trend Toward Worse Prognosis, Unless Treated / Thus, TAVI Should not be Withheld in AS-CA.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 43
- By:
- Publication type:
- Article
22
Proof-Of-Concept Study/Calcium-Induced Autonomic Denervation: Injection of CaCl<sub>2</sub> into the 4 Major Atrial Ganglionated Plexi (GPs) Reduced Post-Op AF Hazard by 63% /Inhibition of GP Function by Ca-Mediated Neurotoxicity May Underlie the Therapeutic Effect.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 42
- By:
- Publication type:
- Article
23
In Coronary Artery Disease (CAD) Patients, Myocardial Fibrosis on Visual Assessment (MF<sub>VA</sub>) plus Quantified on Cardiac Magnetic Resonance (CMR) "Gray Zone" Myocardial Fibrosis (GZF<sub>3SD</sub>) Mass was More Strongly Associated with Sudden Cardiac Death (SCD) and Ventricular Arrhythmias (VAs) than Left Ventricular Ejection Fraction (LVEF) / In Selecting Patients for ICDs, Assessment of MFVA Followed by Quantification of GZF<sub>3SD</sub> Mass May be Preferable to LVEF.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 42
- By:
- Publication type:
- Article
24
TAVI in Failed Transcatheter Aortic Valves (TAV-in-TAV) vs Surgical Aortic Valves (TAV-in-SAV): TAVin-TAV Conferred Higher Procedural Success and Similar Procedural Safety or Mortality.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 42
- By:
- Publication type:
- Article
25
RHAPSODY: Rilonacept vs Placebo Confers Rapid Resolution of Recurrent Pericarditis Episodes and Lower Risk of Pericarditis Recurrence.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 42
- By:
- Publication type:
- Article
26
SOLOIST-WHF: In Patients With Diabetes and Recent Worsening Heart Failure (HF), Sotagliflozin Therapy, Initiated Before or Shortly After Discharge, Resulted in a Significantly Lower Total Number of Deaths from Cardiovascular (CV) Causes and Hospitalizations and Urgent Visits for HF.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 41
- By:
- Publication type:
- Article
27
GALACTIC-HF: Among Patients With Heart Failure and a Reduced Ejection, those on Omecamtiv Mecarbil Had a Lower Incidence of a Composite of a HF Event or Death from Cardiovascular Causes than on Placebo.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 41
- By:
- Publication type:
- Article
28
STOP AF First: Cryoballoon Ablation as Initial Therapy was Superior to Drug Therapy for Prevention of Recurrence in Patients With Paroxysmal Atrial Fibrillation (AF) with Uncommon Serious Procedure-Related Adverse Events.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 41
- By:
- Publication type:
- Article
29
EARLY-AF: Cryoballoon Ablation Lowers Rate of Atrial Fibrillation (AF) Recurrence Among Patients Receiving Initial Treatment for Symptomatic, Paroxysmal AF, Compared With Antiarrhythmic Drug (AAD) Therapy, as Assessed by Continuous Cardiac Rhythm Monitoring.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 41
- By:
- Publication type:
- Article
30
Cavotricuspid Isthmus Ablation Using a Novel High-Density Automated Electroanatomical Contact Mapping System.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 39
- By:
- Publication type:
- Article
31
Anticoagulation with Enoxaparin in Patients with Obesity.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 34
- By:
- Publication type:
- Article
32
COVID-19 Vaccines: Cardiovascular Perspectives.
- Published in:
- Rhythmos, 2021, v. 16, n. 2, p. 22
- By:
- Publication type:
- Article